当前位置:首页 - 行情中心 - 科源制药(301281) - 财务分析

科源制药

(301281)

  

流通市值:31.94亿  总市值:48.75亿
流通股本:7095.20万   总股本:1.08亿

科源制药(301281)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.31亿元,每股收益0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益139339.49万元,未分配利润31358.56万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产179079.60万元,负债39740.11万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入161,302,912.39398,227,849.61302,688,076.14227,866,001.27
营业总成本128,319,432.51363,809,681.93278,777,760.56191,517,077.84
其他经营收益
营业利润33,400,847.5332,386,693.0528,023,489.3239,127,935.3
利润总额32,692,682.7616,778,197.9331,944,668.743,765,022.72
净利润30,536,07216,376,551.1231,261,045.1742,641,961.6
每股收益
其他综合收益----
综合收益总额30,536,07216,376,551.1231,261,045.1742,641,961.6
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计731,572,504.49652,390,779.87633,272,572.62655,916,046.11
非流动资产:
非流动资产合计1,059,223,481.71,035,274,249.91972,573,730.58948,429,558.82
资产总计1,790,795,986.191,687,665,029.781,605,846,303.21,604,345,604.93
流动负债:
流动负债合计239,674,612.81175,987,292.04112,547,307.04100,067,523.62
非流动负债:
非流动负债合计157,726,516.08155,495,990.92121,851,690.85122,175,539.54
负债合计397,401,128.89331,483,282.96234,398,997.89222,243,063.16
所有者权益(或股东权益):
归属于母公司股东权益合计1,392,300,744.311,355,550,280.61,370,849,035.031,381,335,721.4
股东权益合计1,393,394,857.31,356,181,746.821,371,447,305.311,382,102,541.77
负债和股东权益合计1,790,795,986.191,687,665,029.781,605,846,303.21,604,345,604.93
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计118,535,673.67339,582,259.15218,869,644.87151,884,597.79
经营活动现金流出小计87,413,694.51296,113,181.46191,629,723.54126,314,818.28
经营活动产生的现金流量净额31,121,979.1643,469,077.6927,239,921.3325,569,779.51
投资活动产生的现金流量:
投资活动现金流入小计8,300,183.93601,827,035.78513,337,958.8444,908,865.5
投资活动现金流出小计36,630,358.68480,411,328.23642,972,436.59383,244,915.81
投资活动产生的现金流量净额-28,330,174.75121,415,707.55-129,634,477.7961,663,949.69
筹资活动产生的现金流量:
筹资活动现金流入小计44,398,432.4570,161,627.8955,395,301.3853,617,376.08
筹资活动现金流出小计1,198,514.6228,378,682.3627,426,656.3525,142,879.52
筹资活动产生的现金流量净额43,199,917.8341,782,945.5327,968,645.0328,474,496.56
汇率变动对现金及现金等价物的影响-204,929.59453,917.96488,714.31513,591.9
现金及现金等价物净增加额45,786,792.65207,121,648.73-73,937,197.12116,221,817.66
期末现金及现金等价物余额344,678,209.59298,891,416.9417,832,571.09207,991,585.87
补充资料:
现金及现金等价物的净增加额-207,121,648.73-116,221,817.66
TOP↑